Literature DB >> 21863326

Churg-strauss syndrome: an update.

Andy Abril1.   

Abstract

Churg-Strauss syndrome is an uncommon disease of unknown cause described initially by Churg and Strauss in 1951. Even though it was initially thought to be a variant of polyarteritis nodosa, its pathological, clinical, and laboratory features show that it is related to the small vessel vasculitides, and it is now classified as an antineutrophil cytoplasmic antibody-associated vasculitis. The presence of asthma, usually of adult onset, along with other allergic symptoms, peripheral and tissue eosinophilia, is specific to this disease. These features usually help clinicians distinguish it from other types of small vessel vasculitis and should alert clinicians about its presence. Two different clinical subtypes defined by the presence of antineutrophil cytoplasmic antibodies recently have been recognized. Recent advances in the treatment and pathophysiology of Churg-Strauss syndrome are reviewed in this article.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21863326     DOI: 10.1007/s11926-011-0205-7

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  52 in total

1.  Renal involvement in Churg-Strauss syndrome.

Authors:  Renato Alberto Sinico; Lucafrancesco Di Toma; Umberto Maggiore; Cinzia Tosoni; Paolo Bottero; Ettore Sabadini; Gaia Giammarresi; Bruno Tumiati; Gina Gregorini; Alberto Pesci; Stefano Monti; Genesio Balestrieri; Giovanni Garini; Filomena Vecchio; Carlo Buzio
Journal:  Am J Kidney Dis       Date:  2006-05       Impact factor: 8.860

2.  Interferon-alpha treatment of four patients with the Churg-Strauss syndrome.

Authors:  E Tatsis; A Schnabel; W L Gross
Journal:  Ann Intern Med       Date:  1998-09-01       Impact factor: 25.391

3.  CCL17/thymus and activation-related chemokine in Churg-Strauss syndrome.

Authors:  Tomáš Dallos; Gisela Ruiz Heiland; Johanna Strehl; Thomas Karonitsch; Wolfgang L Gross; Frank Moosig; Constanze Holl-Ulrich; Jörg H W Distler; Bernhard Manger; Georg Schett; Jochen Zwerina
Journal:  Arthritis Rheum       Date:  2010-11

4.  HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome.

Authors:  Augusto Vaglio; Davide Martorana; Umberto Maggiore; Chiara Grasselli; Adele Zanetti; Alberto Pesci; Giovanni Garini; Paolo Manganelli; Paolo Bottero; Bruno Tumiati; Renato A Sinico; Mario Savi; Carlo Buzio; Tauro M Neri
Journal:  Arthritis Rheum       Date:  2007-09

Review 5.  Eosinophils as antigen-presenting cells in allergic upper airway disease.

Authors:  Praveen Akuthota; Haibin Wang; Peter F Weller
Journal:  Curr Opin Allergy Clin Immunol       Date:  2010-02

6.  Pleural effusion in Churg-Strauss syndrome.

Authors:  S C Erzurum; G A Underwood; D L Hamilos; J A Waldron
Journal:  Chest       Date:  1989-06       Impact factor: 9.410

Review 7.  Recent progress in the genetics of Wegener's granulomatosis and Churg-Strauss syndrome.

Authors:  Stefan Wieczorek; Julia U Holle; Jörg T Epplen
Journal:  Curr Opin Rheumatol       Date:  2010-01       Impact factor: 5.006

Review 8.  Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome.

Authors:  J G Lanham; K B Elkon; C D Pusey; G R Hughes
Journal:  Medicine (Baltimore)       Date:  1984-03       Impact factor: 1.889

9.  Illustrated histopathologic classification criteria for selected vasculitis syndromes. American College of Rheumatology Subcommittee on Classification of Vasculitis.

Authors:  J T Lie
Journal:  Arthritis Rheum       Date:  1990-08

10.  Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients.

Authors:  Camillo Ribi; Pascal Cohen; Christian Pagnoux; Alfred Mahr; Jean-Pierre Arène; Dominique Lauque; Xavier Puéchal; Philippe Letellier; Philippe Delaval; Jean-François Cordier; Loïc Guillevin
Journal:  Arthritis Rheum       Date:  2008-02
View more
  6 in total

1.  Carbimazole-induced lupus.

Authors:  Ihteshamul Haq; Michael D Sosin; Simon Wharton; Anindya Gupta
Journal:  BMJ Case Rep       Date:  2013-02-06

2.  Selective IgA deficiency mimicking Churg-Strauss syndrome and hypereosinophilic syndrome: a case report.

Authors:  Noriyuki Takahashi; Takeshi Kondo; Mamiko Fukuta; Ayumu Takemoto; Yuichiro Takami; Motoki Sato; Takafumi Ando; Naozumi Hashimoto; Tomio Suzuki; Juichi Sato; Masahiro Yamamura; Nobutaro Ban
Journal:  Nagoya J Med Sci       Date:  2013-02       Impact factor: 1.131

3.  Clinical study of renal impairment in patients with propylthiouracil-induced small-vessel vasculitis and patients with primary ANCA-associated small-vessel vasculitis.

Authors:  Xiaozhi Cao; Weiyuan Lin
Journal:  Exp Ther Med       Date:  2013-04-15       Impact factor: 2.447

4.  Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) presenting as diffuse myositis.

Authors:  Marc-Etienne Parent; Sandrine Larue; Benjamin Ellezam
Journal:  BMC Musculoskelet Disord       Date:  2014-11-21       Impact factor: 2.362

5.  Association of the blood eosinophil count with end-organ symptoms.

Authors:  Ole Weis Bjerrum; Volkert Siersma; Hans Carl Hasselbalch; Bent Lind; Christen Lykkegaard Andersen
Journal:  Ann Med Surg (Lond)       Date:  2019-07-09

6.  Churg-Strauss syndrome associated with antiphospholipid antibodies in a patient with recurrent myocardial and cerebral ischemia.

Authors:  Marino Paroli; Alessandro Polidoro; Simone Romano; Daniele Accapezzato
Journal:  Int Med Case Rep J       Date:  2012-11-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.